drugset
drugset / Trial / NCT06656026

Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

NCT06656026 ↗

Phase 2 Completed 72 enrolled Guangdong Raynovent Biotech Co., Ltd
RandomizedParallel-groupOpen-labelBasic science

Summary

This trial is conducted in China. The aim of the trial is to investigate safety,pharmacokinetics and pharmacodynamics of ZSP1273 granules

Timeline

Start
2024-11-30
Primary completion
2025-06-30
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Onradivir Small molecule — Oral

Indications

influenza